international dermatology outcome measures

2016 IDEOM Winter Newsletter

Payer’s Roundtable

On Friday, January 29, 2016 – IDEOM, in collaboration with the NPF, held a roundtable meeting to bring to the table and better understand how payers define value/quality and how outcome measures are used by payer decision-making. At the table were IDEOM Board members, NPF leaders, patients and payers from BlueCross BlueShield, Medicaid and other healthcare consultants in high level positions.

IDEOM’s MISSION:

  • To establish patient-centered measurements to enhance research and treatment for those with dermatologic disease
  • To ensure that the inclusion of the perspectives of patients, health economists, payers, physicians and regulatory agencies are included from the onset
  • To establish validated and standardized outcome measures that satisfy the needs of all stakeholders and can be applied to clinical research and clinical practice

This past meeting with the payers was groundbreaking for IDEOM and all its stakeholders, and we are happy to announce that we are actively growing our stakeholder payer contact list so we can thoroughly carry out our mission in measuring outcomes.  A full report to all IDEOM stakeholders will be give a the upcoming IDEOM 2016 meeting in Washington, D.C., as well as a keynote address from Kendall Marcus, MD, Director, Division of Dermatology and Dental Products (DDDP).



IDEOM gratefully acknowledges Eli Lilly and the David M.C. Ju Foundation for their continued support.

 

IDEOM 2016


Wednesday, March 2, 2016
The Westin Washington, D.C. City Center
1400 M Street Northwest, Washington, D.C. 20005

The International Dermatology Outcome Measures (IDEOM) meeting took place in Washington, D.C. on March 2, 2016 at The Westin Washington, D.C. City Center, 1400 M Street Northwest – Washington, DC 20005. Breakfast began at 7:30am and adjourned with a reception at 6:00pm.

Highlights include:

  • Results of Payers Roundtable: Collaboration with the NPF
  • Invited Presentation by Kendall Marcus MD –FDA’s Dermatology Division Director
  • Choosing Core Domains and Forming Workgroups for Psoriasis Outcomes
  • Introducing Hidradenitis Suppurativa IDEOM Workgroup
    Presentation by the Acne Core Outcomes group (ACORN)


For further information,please contact Amanda Pacia by Email or call (650) 288-5339.



Thanks to Our Crporate Sponsors & Donors

IDEOM’s Mission

• To establish patient-centered measurements to enhance research and treatment for those with dermatologic disease

• Perspectives of patients, health economists, payers, physicians and regulatory agencies are included from the onset

• IDEOM’s goal is to establish validated and standardized outcome measures that satisfy the needs of all stakeholders and can be applied to clinical research and clinical practice

Powered by Wild Apricot Membership Software